Founded
2015
Team Size
2000
Total Funding
₹1,835 Cr
Valuation
₹4,560 Cr
PharmEasy is India's leading online pharmacy and healthcare platform offering medicine delivery, diagnostic tests, and teleconsultation.
Core Differentiator
Integrated platform combining medicine delivery, diagnostics, and teleconsultation with pan-India reach and hyperlocal fulfillment infrastructure.
Target Market
Middle-class Indian households seeking convenient, affordable healthcare services
Key Innovation
Asset-light model leveraging network of 90,000+ retail pharmacies for last-mile delivery while maintaining quality control
Large pharmacy partner network and customer base creating two-sided marketplace advantages
Strong brand recall in e-pharmacy space with significant first-mover advantages in key markets
Licenses and compliance infrastructure across states, creating barriers for new entrants
Customer health data and prescription patterns enabling personalized recommendations
₹255 Cr
Total Raised
2
Rounds
Rights Issue
Latest · Dec 28, 2025
Backed by
Unlock the full funding history below — every round's amount, valuation & investors.
Series F
2024-04-10
₹220 Cr
Investors
Rights Issue
Dec 28, 2025
₹35 Cr
Pharmeasy-parent’s loss narrows in Q1, revenue up 10%
PharmEasy Claims To Be Debt Free After Paring More Stake In Thyrocare
PharmEasy-Owned Thyrocare’s Q1 Profit Soars 34% To ₹51 Cr
PharmEasy Cofounders’ Home Interiors Startup AllHome Raises ₹200 Cr
Pharmeasy founders’ new venture All Home raises Rs 200 crore; valuation doubles
PharmEasy co-founders’ startup AllHome raises Rs 200 Cr at Rs 2,000 Cr valuation
Location
Website
Visit WebsiteAnnual Revenue
₹4,200 Cr
Growth Rate
35%
Funding Rounds
2